Alyeska Investment Group’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,000
Closed -$1.75M 476
2017
Q2
$1.75M Buy
+5,000
New +$1.75M 0.01% 338